title: Delayed-onset neutropenia in a patient receiving rituximab as treatment for refractory kidney transplantation.
authors.forename: Naoki
authors.initials: N
authors.lastname: Mitsuhata
authors.forename: Ryuji
authors.initials: R
authors.lastname: Fujita
authors.forename: Seiichi
authors.initials: S
authors.lastname: Ito
authors.forename: Makoto
authors.initials: M
authors.lastname: Mannami
authors.forename: Kojima
authors.initials: K
authors.lastname: Keimei
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects* / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology*; D008875:Middle Aged; D009503:Neutropenia / Q000139:chemically induced*; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab